Publications & Presentations

We would like to thank our patients for their participation in research studies. Your contribution has made a lasting impact on the field and will advance the care of future patients!

Selected Publications and Presentations

• Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
• A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study
• Use of the BASDAI in Psoriatic Arthritis Patients With and Without Axial Disease
• The impact of dietary interventions in psoriatic arthritis
• H. Ralph Schumacher
• Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial
• Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
• Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
• Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System
• Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials
• Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study

PubMed Feed

• Risk factors for relapse in ANCA-associated vasculitis among patients with relapse after induction of remission with rituximab.
  Arthritis & rheumatology (Hoboken, N.J.). 2025 Dec 18; Authors: Romich E, Baker JF, Riley TR 4th, Green I, Rhee RL, McAlear CA, Specks U, Smith RM, Jayne DR, Merkel PA, RITAZAREM Investigators

• High Disease Activity is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis.
  Joint bone spine. 2025 Dec 17;:106020; Authors: Wysham KD, Brubeck HF, Baraff A, Roul P, Olave M, Richards JS, Monach P, Shoback DM, Katz PP, Sauer BC, Wallace B, Garcia JM, Cannon GW, Mikuls TR, England BR, Baker JF

• Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.
  Rheumatology and therapy. 2025 Dec 15; Authors: Gladman DD, Eder L, Selmi C, Mease PJ, Ogdie A, Lozenski K, Adamson E, Sharaf M, Rampakakis E, Pina Vegas L, Coates LC

• Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk.
  Arthritis care & research. 2025 Dec 14; Authors: Coziahr K, Wheeler AM, Luedders BA, Duryee M, Frideres H, Wysham KD, Cannon GW, Kunkel G, Ascherman DP, Monach PA, Kerr GS, Reimold AM, Matson SM, Baker JF, Thiele GM, Mikuls TR, England BR

• Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
  Rheumatology and therapy. 2025 Dec 4; Authors: Ogdie A, Middaugh N, Blachley T, Bourgeois T, Ling YL, Mundayat R, Fallon L, Masri KR, Mease PJ

• Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study.
  The Journal of rheumatology. 2025 Dec 3; Authors: Thrastardottir T, Bjornsson AH, Ogdie A, Hauksdottir A, Kristinsson SY, Gudbjornsson B, Love TJ, ICEBIO

• Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study.
  Drugs - real world outcomes. 2025 Dec;12(4):525-539 Epub 2025 Aug 29; Authors: Armstrong AW, Mburu S, Gondo GC, Kornyeyeva E, Frade S, Ogdie A

• Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.
  Nature medicine. 2025 Dec;31(12):4160-4171 Epub 2025 Oct 6; Authors: McInnes IB, Coates LC, Mease PJ, Ogdie A, Kavanaugh A, Eder L, Schett G, Kivitz A, McGonagle D, Brennan N, Godwood A, Cullen E, Reich K, Ritchlin CT, Merola JF

• Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody Status.
  The Journal of rheumatology. 2025 Dec 1; Authors: Wipfler K, Baker JF, Sayles H, Park SH, Wittstock K, Mikuls TR, Michaud K

• Frailty carries an increased risk of death in rheumatoid arthritis.
  Seminars in arthritis and rheumatism. 2025 Dec;75:152872 Epub 2025 Nov 7; Authors: Bhide SA, Roul P, England BR, Brubeck HF, Cannon GW, Singh N, Loecker C, Kunkel G, Mikuls TR, Shoback DM, Michaud K, Katz PP, Garcia JM, Orkaby AR, Baker JF, Wysham KD